Evidence map›Paper›PMID 41484459›Full record

ArticleEuropean journal of human genetics : EJHG2026

Impact of BRCA1/2 status on young women's sexual function, relationships, and reproduction after predictive genetic testing.

Laura E Forrest, Rowan Forbes Shepherd, Timothy Spelman, Louise Keogh, Mary-Anne Young, Sarah Powell, Catherine Beard, Lucinda Salmon, Linda Warwick, Rachel Williams and 3 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Laura E ForrestParkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia. laura.forrest@petermac.org.ORCID http://orcid.org/0000-0002-1126-4971
Rowan Forbes ShepherdParkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Timothy SpelmanSir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
Louise KeoghMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Mary-Anne YoungKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID http://orcid.org/0000-0002-2493-6394
Sarah PowellInherited Cancers Australia, Narrabeen, NSW, Australia.ORCID http://orcid.org/0009-0004-7750-6189
Catherine BeardParkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-9399-0709
Lucinda SalmonClinical Genetics, Austin Health, Heidelberg, VIC, Australia.
Linda WarwickACT Genetics Service, ACT Health, Phillip, ACT, Australia.
Rachel WilliamsHereditary Cancer Centre, Prince of Wales, Randwick, NSW, Australia.
Jo BurkeSchool of Medicine, University of Tasmania, Hobart, TAS, Australia.
Rebecca D'SouzaGenetics Services of Western Australia, King Edward Memorial Hospital, Subiaco, WA, Australia.
Paul A JamesParkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-4361-4657

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The experiences and outcomes for women identified with a BRCA1/2 pathogenic variant during young adulthood are qualitatively described but not well quantified. This study investigated the impact of BRCA1/2 status on women's reproduction, intimate partner relationships, and sexual functioning. Australian women aged 18-40 years who had predictive BRCA1/2 testing, received either a positive or negative result, and had no personal cancer history, completed an online survey that used a case-control design. Outcome measures included childbearing, use of reproductive technologies, relationship status, and sexual functioning. 579 women participated (62.0% with a BRCA1/2 PV; 38.0% without a BRCA1/2 PV). More women with a BRCA1/2 PV had children compared to those who did not (49.0% c.f., 40.5%; p = 0.045). BRCA1/2 status did not predict whether women were partnered at survey completion (Odds Ratio 1.20; 95% CI 0.80, 1.78) or their sexual functioning over the previous month (β-coefficient -0.08; 95% CI -1.15, 0.98). Women with a BRCA1/2 PV were more likely to have children after genetic testing (OR 1.83: 95% CI 1.05, 3.21) and were more likely to have a greater number of children after genetic testing (β-coefficient 0.41; 95% CI 0.10, 0.73) compared to women without a BRCA1/2 PV, after adjustment for confounders. Receiving a positive predictive BRCA1/2 result is associated with an increased likelihood of childbearing and having a greater number of children compared to receiving a negative predictive BRCA1/2 result. These findings contribute to the evidence base to inform long-term follow-up for women after predictive BRCA1/2 testing.

Indexed as

BRCA1 ProteinBRCA2 ProteinGenetic TestingReproductionSexual BehaviorAdolescentAdultAustraliaCase-Control StudiesFemaleHumansYoung AdultBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Identifiers

PMID41484459
PMCPMC13550612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.